FINWIRES · TerminalLIVE
FINWIRES

Wedbush Adjusts Intellia Therapeutics Price Target to $12 From $17, Maintains Neutral Rating

By

Price: $10.97, Change: $-0.35, Percent Change: -3.09%

Related Articles